Abstract:Background:The prognosis of adult B‐cell acute lymphoblastic leukemia (B‐ALL) remains poor due to drug resistance and relapse although the remission rate reaches 80%∼90%. Identifying molecular abnormalities associated with important cellular activities may help to improve the B‐ALL risk stratification and provide potential therapeutic targets. We have previously found that the transcript level of Ras‐related dexamethasone‐induced 1(RASD1) is abnormally increased in adult B‐ALL bone marrow mononuclear cells (BMMNCs) by bioinformatics and quantitative PCR, suggesting that it may be involved in the pathogenesis of B‐ALL. RASD1 is a member of the Ras superfamily. Its abnormal expression has been reported in multiple solid tumors. However, its clinical relevance and biological role in hematopoietic malignancies, especially in B‐ALL remain to be elucidated.Aims:To determine the clinical significance of RASD1 transcript levels in adult B‐ALL and to study its biological role and the potential mechanism in B‐ALL.Methods:Quantitative real‐time polymerase chain reaction(RT‐qPCR) was used to detect RASD1 transcript levels in BMMNCs from 90 newly diagnosed Philadelphia chromosome(Ph)‐negative B‐ALL and 40 healthy donors. The correlation between RASD1 transcript levels and relapse was analyzed. The biological function and potential mechanism were studied with RASD1‐overexpressing and knockdown human B‐ALL cell lines constructed by lentiviral infection. A xeno‐transplant mouse model was used to study the effect of RASD1 overexpression on proliferation in vivo.Results:The transcript levels of RASD1 in bone marrow mononuclear cells from 90 Philadelphia chromosome(Ph)‐negative adult B‐ALL (81.76%, 0.22%∼1824.52%) were significantly higher than those of 40 healthy controls (7.59%, 0.46%∼38.66%, P < 0.001). Patients with low RASD1 transcript levels had a significantly higher 5‐year cumulative incidence of relapse (CIR, 52.0% [37.4%, 66.6%] vs. 36.2% [22.2%,50.2%]; P = 0.013) and a lower relapse‐free survival (RFS, 47.5% [32.9%,62.1%] vs. 63.1% [49.0%,77.2%]; P = 0.012) than patients with high RASD1 transcription levels. Multivariate analysis showed that low RASD1 transcript level was an independent risk factors for CIR and RFS in patients with Ph‐negative B‐ALL (CIR: HR = 3.367[1.668,6.796], P = 0.001; RFS:HR = 2.938 [1.427,6.047], P = 0.003). Functional analysis showed that overexpression of RASD1 in BALL‐1 and Nalm6 cells inhibited cell proliferation, cell cycle progression and survival after exposure to chemotherapeutics including daunorubicin, methotrexate and cytarabine. In contrast, RASD1 knockdown in Sup‐B15 cells showed the opposite effects. The role of RASD1 in inhibiting cell growth was verified in a tumor‐bearing mouse model. Western Blot showed that overexpression of RASD1 caused decreased levels of mTOR and p70S6K phosphorylation, increased expression of LC3BII/I and Beclin‐1, suggesting that mTOR/p70S6K signaling pathway and autophagy may be involved in RASD1‐mediated regulation of cell proliferation.Summary/Conclusion:The transcript levels of RASD1 in BMMNCs from newly diagnosed Ph‐negative adult B‐ALL were significantly higher than those of healthy controls. A low RASD1 transcript level was independently correlated with a higher CIR and a lower RFS. Overexpression of RASD1 inhibited cell proliferation both in vitro and in vivo. mTOR/p70S6K signaling pathway and autophagy may be involved in RASD1‐mediated regulation of proliferation in B‐ALL cells.image

Dehydropeptidase 1 Promoted Survival And Cell Cycle Progression Through Regulation Of Creb And P53 Pathways In B-Cell All

The Clinical Significance and Biological Function of DPEP1 in B-cell Acute Lymphoblastic Leukemia

DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemia

Expression and Clinical Significance of Phospholipase D1 in De Novo Acute Myeloid Leukemia

Acute Myeloid Leukemia Cell-Intrinsic PD-1 Functions Promoting Leukemia Development by Recruiting SHP2

Prognostic Significance of the Tumor Suppressor Protein P53 Gene in Childhood Acute Lymphoblastic Leukemia.

Overexpression of Lymphoid Enhancer‐binding Factor‐1 (LEF1) is a Novel Favorable Prognostic Factor in Childhood Acute Lymphoblastic Leukemia

Interfering B cell receptor signaling via SHP-1/p-Lyn axis shows therapeutic potential in diffuse large B-cell lymphoma

Expression of DEK in Pancreatic Cancer and Its Correlation with Clinicopathological Features and Prognosis

The Non-Cell-autonomous Function of ID1 Promotes AML Progression Via ANGPTL7 from the Microenvironment.

Dpep Inhibits Cancer Cell Growth and Survival via Shared and Context-Dependent Transcriptome Perturbations

DPEP1 promotes the proliferation of colon cancer cells via the DPEP1/MYC feedback loop regulation

High Expression of BCL11A Predicts Poor Prognosis for Childhood MLL-r ALL

PF166 RASD1 INHIBITS THE PROLIFERATION OF LEUKEMIA CELLS AND CORRELATES WITH LEUKEMIA RELAPSE IN ADULTS WITH PHILADELPHIA CHROMOSOME‐NEGATIVE B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA

BAP1-mediated MAFF deubiquitylation regulates tumor growth and is associated with adverse outcomes in colorectal cancer

Abstract LB-365: Unfolded Protein Response Regulator BIP/HSPA5 As a Chemoresistance Biomarker and Molecular Target in Acute Lymphoblastic Leukemia

Abstract A003: DPEP1 maintains microsatellite stability in colorectal cancer at the tumor microenvironment interface

PELI2 Regulates Early B-cell Progenitor Differentiation and Related Leukemia Via the IL-7R Expression.

DUSP1 Signaling Pathway Regulates Cytarabine Sensitivity in Acute Myeloid Leukemia

Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia

HDAC2-miR183-5p Epigenetic Circuit Contributes to the Growth of Philadelphia Chromosome-Positive B-cell Acute Lymphoblastic Leukemia via PTEN/AKT and c-MYC Signaling Pathway